Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) is now available.
Asymchem Laboratories (Tianjin) Co., Ltd. has convened its first H Shares Class Meeting of 2026 for 17 April 2026 in Tianjin, following its extraordinary general meeting and A shares class meeting, to seek H-shareholder approval on several governance and capital-related matters. The agenda includes special resolutions to repurchase and cancel portions of restricted A shares granted under the 2025 A Share Scheme on two prior proposal dates and to amend the Articles of Association, with the company also setting a register closure period and transfer cut-off to determine H shareholders’ eligibility to attend and vote.
The company has specified that H shareholders must lodge share certificates and transfer documents with its Hong Kong share registrar by 13 April 2026, with the register of members closed from 14 to 17 April 2026, during which no H share transfers will be processed. These steps, overseen by Chairperson and CEO Dr. Hao Hong and the board, are designed to formalize participation in decisions affecting the firm’s share capital structure and corporate governance framework, potentially refining its equity incentive arrangements and strengthening shareholder oversight.
The most recent analyst rating on (HK:6821) stock is a Hold with a HK$90.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong as a Class H share issuer. The company operates in the pharmaceutical and biotechnology services sector, focusing on contract development and manufacturing activities for global drugmakers and related industry stakeholders.
Average Trading Volume: 301,032
Technical Sentiment Signal: Sell
Current Market Cap: HK$36.55B
See more data about 6821 stock on TipRanks’ Stock Analysis page.